Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomalies.
作者信息
Davies Olivia M T, Garzon Maria C, Frieden Ilona J, Cottrell Catherine E, Gripp Karen W, Saneto Russell P, Shwayder Tor, Mirzaa Ghayda M, Drolet Beth A
机构信息
Medical College of Wisconsin, Milwaukee, Wisconsin.
Departments of Dermatology and Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
出版信息
J Am Acad Dermatol. 2022 Jul;87(1):162-164. doi: 10.1016/j.jaad.2021.06.877. Epub 2021 Jul 6.
Abstract
摘要
相似文献
1
Cutaneous vascular anomalies associated with a mosaic variant of AKT3: Genetic analysis continues to refine the diagnosis, nomenclature, and classification of vascular anomalies.
J Am Acad Dermatol. 2022 Jul;87(1):162-164. doi: 10.1016/j.jaad.2021.06.877. Epub 2021 Jul 6.
2
Mosaic pathogenic variants in AKT3 cause capillary malformation and undergrowth.
Am J Med Genet A. 2023 May;191(5):1442-1446. doi: 10.1002/ajmg.a.63121. Epub 2023 Jan 25.
3
Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants.
Am J Med Genet A. 2024 Jun;194(6):e63551. doi: 10.1002/ajmg.a.63551. Epub 2024 Feb 6.
4
Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Pathway.
J Mol Diagn. 2017 Jul;19(4):487-497. doi: 10.1016/j.jmoldx.2017.04.001. Epub 2017 May 11.
5
Verrucous Hemangioma or Verrucous Venous Malformation? Towards a Classification Based on Genetic Analysis.
Actas Dermosifiliogr. 2016 Jun;107(5):427-8. doi: 10.1016/j.ad.2015.07.016. Epub 2015 Dec 17.
6
Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations.
J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1066-72. doi: 10.1111/j.1468-3083.2009.03263.x. Epub 2009 Apr 29.
7
Molecular Diagnosis of Mosaic Overgrowth Syndromes Using a Custom-Designed Next-Generation Sequencing Panel.
J Mol Diagn. 2017 Jul;19(4):613-624. doi: 10.1016/j.jmoldx.2017.04.006. Epub 2017 May 11.
8
Mosaic RASopathy due to KRAS variant G12D with segmental overgrowth and associated peripheral vascular malformations.
Am J Med Genet A. 2021 Oct;185(10):3122-3128. doi: 10.1002/ajmg.a.62386. Epub 2021 Jun 11.
9
Vascular anomalies: Classification and management.
Handb Clin Neurol. 2021;176:345-360. doi: 10.1016/B978-0-444-64034-5.00003-1.
10
How we approach genetics in the diagnosis and management of vascular anomalies.
Pediatr Blood Cancer. 2022 Aug;69 Suppl 3:e29320. doi: 10.1002/pbc.29320.
引用本文的文献
1
The phenotypic and genetic spectrum of AKT3-related neurodevelopmental condition.
Sci Rep. 2025 Mar 3;15(1):7484. doi: 10.1038/s41598-025-92027-3.
2
Targeted therapy for capillary-venous malformations.
Signal Transduct Target Ther. 2024 Jun 17;9(1):146. doi: 10.1038/s41392-024-01862-9.
3
Drug repurposing for cancer therapy.
Signal Transduct Target Ther. 2024 Apr 19;9(1):92. doi: 10.1038/s41392-024-01808-1.
4
[Update on nevi and nevoid skin disorders].
Dermatologie (Heidelb). 2023 May;74(5):310-315. doi: 10.1007/s00105-023-05135-4. Epub 2023 Mar 17.
5
Mosaic pathogenic variants in AKT3 cause capillary malformation and undergrowth.
Am J Med Genet A. 2023 May;191(5):1442-1446. doi: 10.1002/ajmg.a.63121. Epub 2023 Jan 25.
6
Targeted treatment of vascular anomalies.
Int J Womens Dermatol. 2021 Nov 2;7(5Part A):636-639. doi: 10.1016/j.ijwd.2021.10.014. eCollection 2021 Dec.
Zotero 插件